Frontiers in Neurology (Apr 2018)
Intermittent Hypoxia Is Associated With High Hypoxia Inducible Factor-1α but Not High Vascular Endothelial Growth Factor Cell Expression in Tumors of Cutaneous Melanoma Patients
- Isaac Almendros,
- Isaac Almendros,
- Isaac Almendros,
- Miguel Ángel Martínez-García,
- Francisco Campos-Rodríguez,
- Erica Riveiro-Falkenbach,
- José L. Rodríguez-Peralto,
- Eduardo Nagore,
- Antonio Martorell-Calatayud,
- Luis Hernández Blasco,
- Luis Hernández Blasco,
- Jose Bañuls Roca,
- Jose Bañuls Roca,
- Eusebi Chiner Vives,
- Alicia Sánchez-de-la-Torre,
- Alicia Sánchez-de-la-Torre,
- Jorge Abad-Capa,
- Jorge Abad-Capa,
- Josep Maria Montserrat,
- Josep Maria Montserrat,
- Amalia Pérez-Gil,
- Valentín Cabriada-Nuño,
- Irene Cano-Pumarega,
- Jaime Corral-Peñafiel,
- Jaime Corral-Peñafiel,
- Trinidad Diaz-Cambriles,
- Olga Mediano,
- Olga Mediano,
- Joan Dalmau-Arias,
- Ramon Farré,
- Ramon Farré,
- Ramon Farré,
- David Gozal,
- On Behalf of the Spanish Sleep Network,
- Elidia Molina Herrera,
- Rosa M. García Martín,
- Maria Niveiro de Jaime,
- Sara Moreno,
- Ferran Barbé Ilia,
- Manuel Sánchez de la Torre,
- Esther de Eusebio,
- Pedro Landete,
- Manuel Moragón Gordon,
- Eva Arias,
- Fernando Masa,
- Carlos González Herrada,
- Cristina Carrera,
- Aida Muñoz Ferrer,
- Aram Boada,
- Ana Fortuna,
- Mercé Mayos,
- Jesús Gardeazabal García
Affiliations
- Isaac Almendros
- Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Isaac Almendros
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Isaac Almendros
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Miguel Ángel Martínez-García
- Respiratory Department, Hospital Universitario y Politécnico la Fe, Valencia, Spain
- Francisco Campos-Rodríguez
- Respiratory Department, Hospital Universitario de Valme, Seville, Spain
- Erica Riveiro-Falkenbach
- Pathology Department, Medical School, Universidad Complutense, Instituto i + 12, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain
- José L. Rodríguez-Peralto
- Pathology Department, Medical School, Universidad Complutense, Instituto i + 12, Hospital Universitario 12 de Octubre, CIBERONC, Madrid, Spain
- Eduardo Nagore
- Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain
- Antonio Martorell-Calatayud
- Dermatology Department, Hospital de Manises, Valencia, Spain
- Luis Hernández Blasco
- Respiratory Department, ISABIAL, Hospital Gral, Univ. Alicante, Alicante, Spain
- Luis Hernández Blasco
- 0Departamento Medicina Clinica, Univ. Miguel Hernandez, Elche, Spain
- Jose Bañuls Roca
- Respiratory Department, ISABIAL, Hospital Gral, Univ. Alicante, Alicante, Spain
- Jose Bañuls Roca
- 0Departamento Medicina Clinica, Univ. Miguel Hernandez, Elche, Spain
- Eusebi Chiner Vives
- 1Respiratory Department, Hospital san Juan de Alicante, Alicante, Spain
- Alicia Sánchez-de-la-Torre
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Alicia Sánchez-de-la-Torre
- 2Respiratory Department, Group of Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain
- Jorge Abad-Capa
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Jorge Abad-Capa
- 3Respiratory Department, Hospital Germans Trias i Pujol, Centro de investigacion Biomedica, Madrid, Spain
- Josep Maria Montserrat
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Josep Maria Montserrat
- 4Respiratory Department, Hospital Clinic-IDIBAPS, Barcelona, Spain
- Amalia Pérez-Gil
- 5Dermatology Department, Hospital de Valme, Seville, Spain
- Valentín Cabriada-Nuño
- 6Respiratory Department, Hospital Universitario Cruces, Bilbao, Spain
- Irene Cano-Pumarega
- 7Respiratory Department, Hospital Universitario de Getafe, Madrid, Spain
- Jaime Corral-Peñafiel
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Jaime Corral-Peñafiel
- 8Respiratory Department, Hospital Universitario S. Pedro Alcántara, Cáceres, Spain
- Trinidad Diaz-Cambriles
- 9Respiratory Department, Hospital 12 de Octubre, Madrid, Spain
- Olga Mediano
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Olga Mediano
- 0Respiratory Department, Hospital Universitario de Guadalajara, CIBER de enfermedades respiratorias, Madrid, Spain
- Joan Dalmau-Arias
- 1Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Ramon Farré
- Unitat de Biofísica i Bioenginyeria, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain
- Ramon Farré
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
- Ramon Farré
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- David Gozal
- 2Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, United States
- On Behalf of the Spanish Sleep Network
- Elidia Molina Herrera
- Rosa M. García Martín
- Maria Niveiro de Jaime
- Sara Moreno
- Ferran Barbé Ilia
- Manuel Sánchez de la Torre
- Esther de Eusebio
- Pedro Landete
- Manuel Moragón Gordon
- Eva Arias
- Fernando Masa
- Carlos González Herrada
- Cristina Carrera
- Aida Muñoz Ferrer
- Aram Boada
- Ana Fortuna
- Mercé Mayos
- Jesús Gardeazabal García
- DOI
- https://doi.org/10.3389/fneur.2018.00272
- Journal volume & issue
-
Vol. 9
Abstract
Epidemiological associations linking between obstructive sleep apnea and poorer solid malignant tumor outcomes have recently emerged. Putative pathways proposed to explain that these associations have included enhanced hypoxia inducible factor (HIF)-1α and vascular endothelial growth factor (VEGF) cell expression in the tumor and altered immune functions via intermittent hypoxia (IH). Here, we examined relationships between HIF-1α and VEGF expression and nocturnal IH in cutaneous melanoma (CM) tumor samples. Prospectively recruited patients with CM tumor samples were included and underwent overnight polygraphy. General clinical features, apnea–hypopnea index (AHI), desaturation index (DI4%), and CM characteristics were recorded. Histochemical assessments of VEGF and HIF-1α were performed, and the percentage of positive cells (0, <25, 25–50, 51–75, >75%) was blindly tabulated for VEGF expression, and as 0, 0–5.9, 6.0–10.0, >10.0% for HIF-1α expression, respectively. Cases with HIF-1α expression >6% (high expression) were compared with those <6%, and VEGF expression >75% of cells was compared with those with <75%. 376 patients were included. High expression of VEGF and HIF-1α were seen in 88.8 and 4.2% of samples, respectively. High expression of VEGF was only associated with increasing age. However, high expression of HIF-1α was significantly associated with age, Breslow index, AHI, and DI4%. Logistic regression showed that DI4% [OR 1.03 (95% CI: 1.01–1.06)] and Breslow index [OR 1.28 (95% CI: 1.18–1.46)], but not AHI, remained independently associated with the presence of high HIF-1α expression. Thus, IH emerges as an independent risk factor for higher HIF-1α expression in CM tumors and is inferentially linked to worse clinical CM prognostic indicators.
Keywords
- melanoma
- intermittent hypoxia
- obstructive sleep apnea
- hypoxia-inducible factor
- vascular endothelial growth factor